The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
The purpose of MED is to improve decision making in Medicaid and other state health purchasing programs. Created in 2006 by the Center for Evidence-based Policy as a self-governing collaboration of state Medicaid and other agencies, MED seeks to provide policymakers and Medical Directors with the tools and resources they need to make evidence-informed decisions. MED provides members with access to systematic reviews of evidence on the effectiveness of health care treatments and equipment, health technologies, and medical products. States are also offered rapid state-specific reviews and may opt to receive technical assistance.
Policymakers and other decision makers often have to make difficult decisions about the benefits and costs of drug coverage. Developed in 2003 by health policy experts in Oregon as a resource for states, DERP applies comparative evidence to drug formulary decisions. The members-only program, consisting of state Medicaid and public pharmacy managers, as well as other decision makers, provides reports and updates about drugs that have the potential to change clinical practice. Developed with input from members about which drugs to research, DERP reports evaluate the efficacy, effectiveness, and safety of drugs in order to improve patient safety while helping government programs contain costs.
The Center for Evidence-based Policy assists states with evidence work for state-specific applications and can help states design or improve their processes for using evidence in policy formation, program design, and stakeholder outreach.
